|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,174.15 INR | -0.01% |
|
+0.29% | -18.93% |
| Oct. 29 | Colgate Debuts First-Ever Visible White Purple Serum | CI |
| Oct. 24 | Nomura Adjusts Colgate-Palmolive (India)'s Price Target to INR2,200 From INR2,350, Keeps at Reduce | MT |
| Capitalization | 591B 6.67B 5.74B 5.29B 5.07B 9.35B 10.18B 62.97B 24.24B 282B 25.01B 24.5B 1,031B | P/E ratio 2026 * |
42.9x | P/E ratio 2027 * | 38.8x |
|---|---|---|---|---|---|
| Enterprise value | 580B 6.54B 5.63B 5.19B 4.97B 9.17B 9.99B 61.77B 23.78B 277B 24.53B 24.03B 1,011B | EV / Sales 2026 * |
9.56x | EV / Sales 2027 * | 8.8x |
| Free-Float |
48.6% | Yield 2026 * |
2.31% | Yield 2027 * | 2.51% |
Last Transcript: Colgate-Palmolive (India) Limited
| 1 day | -0.01% | ||
| 1 week | +0.29% | ||
| Current month | -3.12% | ||
| 1 month | -1.27% | ||
| 3 months | +0.93% | ||
| 6 months | -16.58% | ||
| Current year | -18.93% |
| 1 week | 2,151.55 |  | 2,195 |
| 1 month | 2,151.55 | | 2,329.85 |
| Current year | 2,151 | | 2,974.8 |
| 1 year | 2,151 | | 3,115 |
| 3 years | 1,434.6 | | 3,893 |
| 5 years | 1,375.55 | | 3,893 |
| 10 years | 787.6 | | 3,893 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-08-31 | |
| Director of Finance/CFO | 56 | 1994-12-31 | |
| Corporate Officer/Principal | - | 2024-01-01 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 2018-08-31 | |
| Director/Board Member | 56 | 2016-10-27 | |
| Director/Board Member | 65 | 2018-05-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | +0.29% | -19.77% | +38.09% | 6.67B | |
| -0.20% | +0.47% | -11.62% | +4.75% | 345B | |
| -2.06% | -3.20% | -1.26% | +10.85% | 146B | |
| +0.83% | +0.57% | +1.61% | -1.22% | 64.33B | |
| -0.94% | -0.90% | -14.65% | +4.67% | 62.91B | |
| -1.94% | +0.49% | +36.02% | -60.04% | 31.78B | |
| -0.66% | -1.30% | -29.44% | - | 31.92B | |
| -0.89% | -2.48% | -26.34% | -7.44% | 23.17B | |
| -1.32% | -2.24% | -12.07% | +6.65% | 18.94B | |
| +1.16% | +2.20% | -2.43% | +35.70% | 13.23B | |
| Average | -0.60% | -0.61% | -8.00% | +3.55% | 74.45B | |
| Weighted average by Cap. | -0.66% | -0.57% | -7.80% | +3.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.65B 684M 589M 543M 520M 959M 1.04B 6.46B 2.49B 28.96B 2.57B 2.51B 106B | 65.77B 742M 639M 588M 564M 1.04B 1.13B 7B 2.7B 31.4B 2.78B 2.72B 115B |
| Net income | 13.78B 155M 134M 123M 118M 218M 237M 1.47B 565M 6.58B 583M 571M 24.01B | 15.21B 172M 148M 136M 130M 241M 262M 1.62B 624M 7.26B 643M 630M 26.52B |
| Net Debt | -11.33B -128M -110M -101M -97.14M -179M -195M -1.21B -465M -5.41B -479M -470M -19.76B | -12.68B -143M -123M -113M -109M -201M -218M -1.35B -520M -6.05B -536M -525M -22.11B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-11-14 | 2,174.15 ₹ | -0.01% | 12,032 |
| 25-11-13 | 2,174.30 ₹ | -0.14% | 6,092 |
| 25-11-12 | 2,177.30 ₹ | -0.30% | 9,545 |
| 25-11-11 | 2,183.75 ₹ | +0.50% | 14,649 |
| 25-11-10 | 2,172.80 ₹ | +0.22% | 15,887 |
Delayed Quote Bombay S.E., November 14, 2025 at 05:00 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- COLPAL Stock
Select your edition
All financial news and data tailored to specific country editions
